A randomized, 2-period, crossover, pharmacodynamic comparability study comparing a pantoprazole spheroid formulation to the currently marketed tablet formulation in subjects with GERD [gastro-esophageal reflux disease] and a history of erosive esophagitis
Phase of Trial: Phase III
Latest Information Update: 21 Feb 2013
At a glance
- Drugs Pantoprazole (Primary)
- Indications Erosive oesophagitis; Gastro-oesophageal reflux
- Focus Pharmacodynamics
- 07 Feb 2013 Actual end date added 1 Nov 2005 as reported by ClinicalTrials.gov record.
- 23 Aug 2007 Results reported.
- 25 May 2007 Status change from in progress to completed.